As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...

Increasingly, companies face a significant dilemma when trying to transform to the quickly evolving new operating models for services. Companies buying services delivered in the new models encounter ...

Leaders, revising their five-year plans every quarter, are constantly seeking ways to reinvent their companies and stay ahead of the pack, given competitors of varying capabilities and scale and ...